Navigation Links
Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
Date:5/29/2008

SAN MARINO, Calif., May 29 /PRNewswire/ -- Epeius Biotechnologies (http://www.epeiusbiotech.com) announced today the results of an on-going Phase I/II study of Rexin-G for metastatic bone and soft tissue sarcoma (J Clin Oncol 26: 14509, 2008). Rexin-G is the first and so far only targeted gene therapy vector that has been tested in the clinic (Nature Reviews/Genetics 2007). In this open label study, cohorts of 6 to 7 patients with all types of sarcoma, including osteosarcoma, Ewing's sarcoma, leiomyosarcoma, malignant fibrous histiocytoma, chondrosarcoma, fibrosarcoma, liposarcoma, angiosarcoma, spindle cell sarcoma, and malignant mixed Mullerian tumor of ovary, were treated with 1 x 10e11 cfu Rexin-G, administered i.v. over 5 minutes, 2 times a week for 4 weeks (Cumulative Dose = 8 x 10e11 cfu) followed by a 2-week rest period. Patients with Grade 1 or less toxicity were given progressive intra-patient dose-escalations consisting of additional treatment cycles of 1 to 2 x 10e11 cfu three times a week for 4 weeks (Cumulative Dose per cycle: 1.2-2.4 x 10e12 cfu).

These higher dosing regimens were associated with prolonged disease stabilization and a median overall survival of greater than 6 months, which was three times longer than that observed in the low-dose group. Further, histologic examination of resected tumors showed 50-90% necrosis. No dose-limiting toxicity was observed, even at the higher doses of Rexin-G, thus confirming that repeated infusions of Rexin-G are safe and well-tolerated. Taken together with previous clinical studies conducted in the Philippines and Japan, these studies confirm the exemplary safety and dose-dependent efficacy of Rexin-G in a broad spectrum of chemotherapy-resistant cancers.

For more information about Rexin-G, on-going clinical trials in the USA and abroad, and/or Epeius pathotropic (disease-seeking) gene delivery systems, please contact Dr. Erlinda M
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
2. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
3. Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
4. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
5. Genmab Announces Updates on Phase III Cancer Studies
6. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
7. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
8. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
11. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Manchester Pharmaceuticals, Inc.(TM) announced today the availability of ... 22, 2009, the US Food and Drug Administration ... suffering from gallstones in whom surgery poses an ... age. ,, Chenodal prescriptions have started to be ... ("Centric"), a specialty pharmacy company. Centric provides ...
(Date:12/14/2009)... Travelers of Interstate 70 west of Indianapolis ... bit more colorful when 10 multicolored art forms are ... going home , will eventually include 34 total ... student at Herron School of Art and Design, through ... ,, Eli Lilly and Company (NYSE: ...
(Date:12/14/2009)... Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced the ... addition of Lt. Gen. Ronald R. Blanck, DO, U.S. ... & Associates, a federal health services consulting firm based ... board now has nine members. ,, Dr. Blanck began ... and battalion surgeon in Vietnam. He retired 32 years ...
Breaking Medicine Technology:Manchester Announces Availability of Chenodal(TM) 2Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4Oxygen Biotherapeutics, Inc. Expands Board of Directors 2LifeNet Health Announces First Bio Implant with New Preservation Technology 6088 1LifeNet Health Announces First Bio Implant with New Preservation Technology 6088 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas Fort Worth Area 6084 1RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas Fort Worth Area 6084 2Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 1Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 2Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 3Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 4Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 5Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 6Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 7
(Date:12/15/2009)... pleased to announce the release of a new report titled, ... markets for clinical devices used to treat and manage urinary ... ... December 15, 2009 -- Marketstrat is pleased to announce the ... The report specifically addresses world markets for clinical devices ...
(Date:12/14/2009)... Research Focuses on Unmarried Young Adults, Attitudes and Behavior ... WASHINGTON, Dec. 15 Nearly all unmarried young ... be planned (94% of men and 86% of women) ... in their lives right now (86% of men and ... The National Campaign to Prevent Teen and Unplanned Pregnancy. ...
(Date:12/14/2009)... ABBOTT PARK, Ill. and HOLLYWOOD, Fla., Dec. ... ABT ) announced today a definitive agreement ... LIMS ), a leading provider of laboratory ... in cash. ,, The acquisition strengthens ... market, providing advanced web-based applications to help ...
(Date:12/14/2009)... WASHINGTON, Dec. 14 The National Organization for ... an immediate end to lifetime and annual health insurance ... Politico, a newspaper distributed widely on Capitol Hill, ... loopholes that would allow caps to continue for most ... "NORD supports health care reform and welcomes the promises ...
(Date:12/14/2009)... practiced in Canada for 13 years under government controlled health care, ... free-market economy. In speaking engagements and in his new book, Health ... the fragility of such a system and its threat to real ... ... Lee Kurisko , a diagnostic radiologist from Minnesota, warns Americans ...
Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2
... Services Panel That,Nursing Home Staffing and Quality Programs Are ... testimony,before a field hearing of the House Human Services ... (THCA) said that in order to,protect the Houston area,s ... essential in the year ahead to initiate a much-needed,discussion ...
... March 13 MassMutual,s Center for,Behavioral Research ... share insights and,best practices regarding automatic features ... a High Performance Plan," the white paper ... sponsors should,consider when evaluating the adoption of ...
... to Select Electronic Medical,Record Systems, COLUMBUS, Ohio, March ... it is launching an innovative new,program, believed to be ... risk for,physicians who wish to adopt an electronic medical ... Excellence Program, which is available exclusively to,OSMA members, will ...
... The American Academy of Cosmetic,Surgery (AACS) announces ... since,2002, the average age for patients receiving invasive ... the mean age of patients seeking the top ... years. The invasive,procedures that have seen the largest ...
... is the only curative treatment in patients with ... a reliable diagnostic procedure is of great importance ... along the bile duct, imaging techniques including ultrasound, ... limited sensitivity for the detection of bile duct ...
... accuracy,s sake, medical professionals should use the same ... taken from different time periods and laboratories, a ... study, published in the January-February issue of the ... at Sacred Heart Medical Center in Eugene, the ...
Other Medicine News:Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 2Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 3Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 4Health News:MassMutual's Center for Behavioral Research(sm) Releases White Paper Regarding Automatic Features in Retirement Plans 2Health News:MassMutual's Center for Behavioral Research(sm) Releases White Paper Regarding Automatic Features in Retirement Plans 3Health News:OSMA Launches EMR Standards of Excellence Program 2Health News:OSMA Launches EMR Standards of Excellence Program 3Health News:OSMA Launches EMR Standards of Excellence Program 4Health News:OSMA Launches EMR Standards of Excellence Program 5Health News:2007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 2Health News:Researchers make case for standardized analysis of cardiac imaging 2